Context and Objectives: Peak bone mass (PBM) is regarded as the most important determinant of osteoporosis. Growing evidence suggests a role of intrauterine programming in skeletal development. We examined PBM and trabecular bone score (TBS) in adults born preterm with very low birth weight (VLBW) or small for gestational age (SGA) at term compared with term-born controls.
B
etween 8% and 26% of infants are born with low birth weight (LBW), depending on geographical region (1) . The survival rate has increased gradually during the past 3 decades, and the first to receive advanced neonatal care have now entered adulthood. Infants with very low birth weight (VLBW) constitute the lower end of the prematurity spectrum and are susceptible to various long-term health consequences (2) (3) (4) . Intrauterine growth restriction (IUGR), often referred to as small for gestational age (SGA), involves an extra vulnerability, even for those born at term (5, 6) .
Growing evidence suggests that LBW is associated with subnormal peak bone mass (PBM) (2, (7) (8) (9) . PBM is usually achieved by the 3rd decade of life, and it is regarded as the most important determinant of osteoporosis (10) . The maternofetal calcium metabolism combined with fetal movement against the uterine wall ensures the optimal bone mass during the prenatal period. Nearly 80% of the neonatal body calcium accumulates during 36 to 38 weeks of gestation (11) . Thus, preterm infants are invariably deprived of the benefits of the last trimester mineralization (11) . A few studies have shown that adults born preterm with VLBW display inferior bone mineral density (BMD) (2, 4, 12) , suggesting a role of intrauterine programming in skeletal development.
Previous studies have focused mainly on BMD in adults born preterm with VLBW (2, 4) . In the present study, we investigated PBM in two groups of adults (25 to 28 years), born preterm with VLBW or SGA at term, compared with term-born controls with normal birth weight (BW). Additionally, trabecular bone score (TBS), a measure of bone microarchitecture was assessed by dual x-ray absorptiometry (DXA), and serum bone markers were analyzed. We also studied the association between weight gain at 1 and 5 years of age and PBM.
Methods

Study design
This study is a follow-up of two cohorts, including white subjects born from 1986 to 1988. One cohort comprised neonates born preterm with BW # 1500 g, admitted to the neonatal care unit at St. Olavs Hospital, Trondheim, Norway. The other cohort was part of a multicenter study addressing risk of being born SGA. Women in their second or third pregnancy from the Trondheim region, carrying singletons, were enrolled before week 20 of pregnancy (13) . A 10% random sample was selected and followed up. Women at risk for delivering an SGA infant were identified according to the following risk factors-prepregnancy weight ,50 kg, previous LBW delivery or perinatal death, cigarette smoking at conception, or chronic diseases (hypertension, renal or heart disease)-and were followed up. Term-born infants ($37 completed gestational weeks) were assigned to the SGA or control group dependent on BW (BW , or $ 10th percentile, respectively, after adjustment for gestational age, sex, and parity) (Fig. 1) . Infants of mothers not followed up during pregnancy were also enrolled in the SGA group when BW , 10th percentile. Data for the present study were collected between June 2013 and September 2014. A flowchart addressing both cohorts is shown in Fig. 1 , whereas a more detailed chart on SGA and controls is included in Supplemental Fig. 1 . The study was approved by the Regional Committee for Medical and Health Research Ethics in Central Norway (no. 2013/636/REK Mid-Norway). Participants gave written informed consent.
Study participants
Eighty-four participants with VLBW, 100 participants with SGA, and 116 controls were eligible at 25 to 28 years of age. Individuals with congenital syndromes, malformations, and physical disabilities were not invited. The VLBW group comprised three subgroups: SGA (n = 16, 31%), appropriate for gestational age (AGA; n = 32, 61%) and large for gestational age (LGA = BW . 90th percentile, n = 4, 8%). Based on previous observations, the SGA groups constituted both growthrestricted and constitutionally small individuals (6). The control group consisted of AGA (n = 66, 88%) and LGA subjects (n = 9, 12%).
Measures
Body weight was recorded to the nearest 0.1 kg, and standing height to the nearest 0.5 cm, using a wall-mounted stadiometer with the stretch stature method. Body mass index (BMI; kilograms per square meter) was calculated. BMC, BMD, and TBS were measured, and blood was collected. Anthropometric data were also available from a subgroup of participants at 1 and 5 years of age.
Participants answered a questionnaire addressing dietary calcium (from milk) and vitamin D intake, smoking, physical activity, previous fractures, age at menarche, medical conditions, and current medications, including contraceptives. The Norwegian standard food validation data were applied to estimate daily calcium and vitamin D intake. Smokers were defined as currently smoking one or more cigarettes per day. Weight-bearing physical activities (occupational, sports, commuting, and leisure time conditioning) were recorded, with focus on frequency, duration, and intensity (Borg's rating scale).
DXA
BMC and BMD at total hip (TH), femoral neck (FN), lumbar spine (LS) (L1 to L4), and whole body (WB) were measured by DXA, applying Hologic Discovery A S/N 83817 (Hologic, Bedford, MA, software version 13.4.2). Calibration with a Hologic anthropomorphic spine phantom was performed daily. All analyses were performed by trained technicians. We used the reference values provided by the manufacturer for the spine and the Third National Health and Nutrition Examination Survey for the hip. BMD Z-scores and absolute values (grams per square centimeter) were applied when comparing groups. For BMC, only absolute values (grams) were used. Because the study population had achieved PBM, we applied the T-score-based definition of osteoporosis according to the proposals of the International Osteoporosis Foundation Committee of Scientific Advisors Working Group on Osteoporosis Pathophysiology (14) . Normal BMD was defined as T-score . 21 .0, osteopenia as T-score # 21.0 to 22.4, and osteoporosis as T-score # 22.5. TBS at the spine was assessed by DXA applying TBS iNsight software version 2.1.0.0 (Medimaps, Pessac, France). The coefficients of variation were 1.1% at LS, 1.3% at TH, and 1.5% at FN.
Serum analyses
Blood samples were collected between 8:00 and 9:00 AM after overnight fasting and stored at 280°C until analyses. Cterminal telopeptide of type 1 collagen (CTX-I) and total procollagen of type 1 N-terminal propeptide (P1NP) were measured by electrochemiluminescence immunoassay at the Hormone Laboratory, Oslo University Hospital. Dickkopf-1, osteoprotegerin (OPG), osteocalcin, and sclerostin were analyzed using multianalyte profiling Milliplex MAP assay, and receptor activator of nuclear factor kB ligand (RANKL) was analyzed by a single analyte assay (Millipore, Billerica, MA). All analyses were done according to the manufacturers' instructions. Ionized calcium, 25-hydroxy vitamin D 3 (25OHD), and parathyroid hormone (PTH) were measured at St. Olavs Hospital, Trondheim, Norway.
Statistical analyses
SPSS Statistics version 22.0 (IBM SPSS Statistics, Chicago, IL) was applied. Three-group comparisons were done by oneway analysis of variance with a Tukey honestly significant https://academic.oup.com/jcemdifferent post hoc analysis for continuous variables with normal distribution. Logarithmic transformation was used for nonparametric data. Kruskal-Wallis and Mann-Whitney U tests were applied for group comparisons of nonparametric continuous variables, and a x 2 test was used for categorical variables. For multiple comparisons of serum parameters, we applied a Bonferroni adjustment to the a level. Based on the number of treatment groups, the significance level was set to P , 0.017. For other analyses a two-sided P , 0.05 was considered significant. Analysis of covariance with a post hoc Bonferroni test was used to adjust for confounding factors. Odds ratios (ORs) with a 95% confidence interval (CI) were calculated by logistic regression. Data are presented as mean with standard deviation (SD) or CI, or median with interquartile range, depending on the distribution.
Results
Altogether, 190 adults agreed to participate. After exclusion of three participants with cerebral palsy and one undergoing sex transformation ( Fig. 1 ), 186 individuals were included (females n = 95, 51%), comprising 52 VLBW, 59 SGA, and 75 controls.
Nonparticipants
Of 300 invited, 110 (36.7%) did not give consent to DXA. Two women were pregnant, and DXA was therefore not recommended ( Fig. 1 ). Sex distribution, BW, and gestational age were similar between participants and nonparticipants (data not shown).
Clinical characteristics
Relevant characteristics are shown in Table 1 . No differences in adult height, body weight, and BMI were observed between the groups. However, when sexstratified, males in the VLBW and SGA groups were shorter than control males (mean difference of 5.5 and 5.1 cm, P = 0.006 and P = 0.007, respectively). SGA females were also shorter than control females (mean difference of 4.3 cm, P = 0.036). Intake of milk and vitamin D and smoking habits did not differ. About 73% of the controls engaged in high-intensity activities vs 42% in the VLBW group (P = 0.003). Exercise intensity and duration of daily physical activity were significantly lower in the VLBW group compared with the other Values are mean (6SD). The number of participants varied with different stages of weight and height measurements. a Borg's rating of perceived exertion scale.
b Weight measured at 1 y: controls, n = 69; SGA, n = 48; VLBW, n = 16.
b Weight measured at 5 y: controls, n = 64; SGA, n = 48; VLBW, n = 16.
d Height measured at 1 y: controls, n = 69; SGA, n = 47; VLBW, n = 7.
e Height measured at 5 y: controls, n = 63; SGA, n = 45; VLBW n = 7.
groups. Eighteen VLBW, 19 SGA, and 28 control participants reported one or more high-energy fractures (overall P = 0.825). One VLBW, two SGA, and one control participant had sustained low-energy fractures (P = 0.711). Age at menarche was higher in VLBW females compared with controls (13.7 6 1.7 vs 12.7 6 1.6 years, respectively, P = 0.042). Chronic diseases were uncommon in our study population [asthma (n = 8), allergy (n = 1), newly diagnosed Crohn's disease (n = 1)], and the occurrence did not differ between the groups. Eleven of these had used glucocorticoids, but not in high doses or long-term (three VLBW, four SGA, four control). Seven used serotonin reuptake inhibitors (four VLBW, two SGA, one control, P = 0.177). Contraceptive pills usage (23 VLBW, 22 SGA, 38 control, P = 0.117) was similar between groups, whereas duration (years) of use was longer in the SGA group, although borderline significant (5.3 6 3.4 VLBW, 7.6 6 2.5 SGA, 6.5 6 3.3 control, P = 0.053). BMD did not differ between current, past, and never users of contraceptives (data not shown).
DXA
Data are shown in Table 2 . The VLBW participants displayed lower mean BMC at all sites. Absolute BMD and Z-scores were significantly lower at FN, TH, and WB, compared with controls. A Z-score difference of 0.6 SD (P = 0.003) at FN, 0.4 SD (P = 0.018) at TH, 0.5 SD (P = 0.007) at WB, and 0.3 SD (P = 0.213) at LS was observed. When controlled for adult weight and height, the significant differences in Z-score persisted at FN (P = 0.003), TH (P = 0.018), and WB (P = 0.015), and also at FN (P = 0.004), TH (P = 0.031), and WB (P = 0.010) when adjusted for calcium intake and physical activity.
The SGA individuals had significantly lower LS-BMC than did controls, but not after adjustment for height and weight. WB-BMC and WB-BMD Z-scores were also lower, albeit borderline significant. Absolute BMD values were not different from the other groups.
The frequency of normal BMD, osteopenia, and osteoporosis at any site differed significantly between the groups (P = 0.022) (Fig. 2) . Crude ORs for having osteopenia/ osteoporosis were significantly higher in VLBW and SGA participants. After adjustment for height, weight, calcium intake, serum vitamin D, smoking, and physical activity, however, the significance persisted only in the VLBW group (Table 3) . TBS was similar between the groups and correlated positively with BMD. Females displayed a higher TBS than did males (1.46 vs 1.42, P = 0.004). Participants with previous fractures had a lower TBS than did those without fractures (1.43 6 0.08 and 1.45 6 0.08, respectively, P = 0.050).
Subanalyses
In sex-stratified analysis, we observed the same pattern with inferior BMC and BMD in the VLBW and SGA groups in both sexes. Due to loss of power, however, fewer significant differences were observed (Supplemental Table 2 ). In another subanalysis, preterm SGA adults exhibited lower BMD at all sites compared with term-born AGA subjects (Supplemental Table 3 ). The significance persisted only at the LS (P = 0.021) when adjusted for current height and weight, and at the LS (P = 0.014) and WB (P = 0.014) when adjusted for calcium and physical activity. None of the other subgroups differed significantly (data not shown).
In the total study population, those born at gestational weeks 28 to 32 displayed lower WB-BMD (P = 0.048) than did those born at 32 to 37 weeks and later. Subjects born during 32 to 37 weeks had significantly lower WB-BMD compared with controls born at 38 to 40 weeks (P = 0.041). They also had lower WB and LS-BMD than did those born postterm at 41 to 43 weeks (P = 0.010 and P = 0.042, respectively). A regression analysis showed an increase of 0.037 units in FN Z-score with each additional week of gestation (95% CI, 0.01 to 0.07, P = 0.01).
Among term-born SGA individuals, six had a BW , 3rd percentile, which indicates growth restriction (6) . When comparing these six with preterm SGA adults (n = 16), those born preterm displayed lower BMD at all sites, although significant only at FN (0.787 vs 1.069, P = 0.009) and WB (1.057 vs 1.155, P = 0.028).
Weight and height gain at 1 and 5 years in relationship to bone parameters
Weight gain during the first year of life correlated with BMC at all sites in the VLBW and SGA groups, but only at LS in controls. Significant correlation with BMD (at most sites) was only seen in the VLBW subjects. Weight gain up to the 5th year was positively correlated with BMC at all sites in SGA adults, but not in VLBW subjects. Height gain during the first year correlated with LS-BMC in SGA adults and controls, whereas height gain up to the fifth year correlated with BMC at most sites in SGA adults and with LS-BMC in controls (Supplemental Table 5 ).
Serum analyses
Data are shown in Table 4 . P1NP and CTX-1 levels did not differ between the groups. Dickkopf-1 was higher in the VLBW group compared with controls, but it was not significant after Bonferroni adjustment to the a level (P = 0.030). No significant correlation was found between Dickkopf-1 levels and BMD. Sclerostin levels, the OPG/ RANKL ratio, 25OHD levels, PTH, and ionized calcium were similar between the groups. Serum 25OHD was ,50 mmol/L in 84.6% of VLBW, 66.1% of SGA, and 66.2% of controls (P = 0.371). Males displayed lower 25OHD and higher PTH levels than did females [mean, 49 vs 67 nmol/L (P = 0.004) and mean, 4.06 vs 3.58 nmol/L (P = 0.065), respectively]. A positive correlation between 25OHD and TBS (r = 0.219, P = 0.003) and a negative correlation between PTH and TBS (r = 20.237, P = 0.001) were observed.
Discussion
In this study we compared PBM and bone quality in subjects born preterm with VLBW and SGA at term. We observed inferior BMC in both groups at age 25 to 28 years compared with their term-born peers with normal BW. The VLBW adults also had lower BMD at most sites. After adjustment for current height and weight, and for calcium intake and physical activity, the significant differences in BMC and BMD persisted in the VLBW group, but not in the term-born SGA group. Both LBW groups displayed a higher OR for osteopenia and osteoporosis than did controls. After adjusting for confounding factors, the significance persisted only in the VLBW group. Our findings are in agreement with Hovi et al. (2) , showing that individuals born preterm with VLBW reach a suboptimal PBM and shorter stature. In contrast to the study by Hovi et al., where the participants were 18 to 27 years of age, all our study subjects had reached PBM, and we can therefore more convincingly state that PBM was attenuated in the VLBW group. We observed that Z-scores at FN and WB were 0.6 and 0.5 units lower than in controls. This implies an increased fracture risk in the future, as a decline of 1 SD is associated with a doubling or even tripling of fracture risk (15) . The inferior BMD could not be explained by lower body height or confounding factors, thus supporting causal factors in fetal life.
In contrast to the VLBW group, the smaller body size seemed to explain the inferior BMC in term-born SGA adults. Recall that the SGA group was a mixture of growth-restricted and constitutionally small individuals. Lack of repeated ultrasound data made differentiation between these two categories challenging. Ananth and Vintzileos (5) suggested that SGA may be justified as a proxy for IUGR in early preterm gestations, whereas term-born SGA infants are more likely to be constitutionally small. Another study (6) proposed that being born at term with BW ,3rd percentile is consistent with IUGR. Six of the 56 SGA subjects in our study had a BW ,3, which may imply IUGR. Our findings suggest that term-born SGA adults have an increased risk of future osteoporosis independent of etiology.
The crude OR for osteopenia/osteoporosis at any site was 2.5 and 2.0 in the VLBW and SGA adults, respectively. These numbers are rather misleading concerning the severity of the problem, as the VLBW subjects exhibited more pronounced osteopenia at more sites than did the SGA group. Osteopenia was frequent also in the control group, with 32% displaying osteopenia at any site, whereas the reported frequency in this age group is ,15% (14) . This may be explained by the high prevalence of vitamin D insufficiency and deficiency in all groups. According to recent suggestions by Ferrari et al. (14) , we chose to use T-score for classification of osteopenia/ osteoporosis because they had reached PBM. The use of T-score in this age group is, however, controversial, and an apparently low areal BMD must be interpreted with caution in prediction of fracture risk.
In the total study population, we found a positive correlation between gestational length and both BMC and BMD. Also, with each additional increase in gestational week, a 0.037 unit increase of FN Z-score was seen, underpinning the importance of the mineralization during the last trimester. Preterm-born SGA subjects exhibited the lowest BMD, illustrating that the combination of IUGR and deprivation of the third trimester is especially harmful for the skeleton.
BMD measured by DXA is a surrogate marker of bone strength, with a strong relationship with fracture risk (2, 15) . In this study we examined TBS, an index of bone microarchitecture, in adults born with LBW (16) . We observed no significant difference in TBS between the groups. Recall that bone material properties, another aspect of bone quality, are not captured by TBS. Thus, an impairment of bone quality cannot be ruled out. TBS was slightly lower in both sexes compared with recently reported data in healthy Italians 18 to 30 years of age (17) . The higher TBS in females may be explained by significantly higher 25OHD and lower PTH levels than in males. We observed lower TBS in those with previous fractures, which may imply increased future fracture risk. In line with this, an association between fractures in childhood and fracture risk in adulthood has been reported (18) . Females in the VLBW group reported a higher age at menarche than did the other groups. This is in agreement with a Chinese study (19) , but in contrast to most studies that show an earlier puberty in subjects born preterm with VLBW (20, 21) . Late menarche is associated with low bone mass at several sites both in premenopausal and postmenopausal women (22, 23) .
Few participants had chronic diseases or used medication that could affect bone. Use of hormonal contraceptives was frequent in all groups. We found no significant difference in BMD between past, current, or never users in any of the groups. Thus, chronic diseases and use of medication could not explain the BMD differences between the groups.
The differences in BMC and BMD were not reflected in bone turnover assessed by P1NP and CTX-1. This is in accordance with results from the Scandinavian birth weight discordant monozygotic twin study (24) . OPG and RANKL were also similar between the groups. The Wnt/b-catenin signaling pathway and its endogenous inhibitor sclerostin are key regulators of osteogenesis (25) . Dickkopf-1 is also an inhibitor of this pathway (25) . Elevated levels of Dickkopf-1 have been observed in postmenopausal osteoporosis, suggesting inhibition of bone formation (26) . We observed no differences in sclerostin levels, whereas Dickkopf-1 levels were higher in the VLBW group compared with controls, but they were not significant after adjustment for multiple comparisons.
The positive correlation between bone mass and weight gain at 1 and 5 years of age is in line with previous studies showing that catch-up growth is beneficial for maximizing PBM (27, 28) . This emphasizes the importance of adequate nutrition during the early years. An optimal calcium intake in childhood and adolescence is shown to influence PBM positively and even more so when combined with exercise (10, 29) . However, few studies have addressed the effect of calcium intake on PBM in those born with LBW (2, 30, 31). Fewtrell (31) observed that the proportion of human milk in the early diet was positively associated with later WB-BMC. In the present study, the consumption of milk was low in all groups, indicating that the total calcium intake was below the recommended intake of 1000 mg. In line with previous findings, the VLBW group reported lower levels of physical activity (32) . This could not, however, explain the inferior PBM.
Worldwide, .11% of deliveries are preterm, representing nearly 15 million births annually (33) . The number of term-born SGA infants is also substantial (34) . The survival rate of infants with VLBW has increased from ;40% in the 1960s to almost 90%, especially in developed countries (35) . Despite advanced current postnatal care and optimal nutrition, it has not succeeded to fully compensate for the deprived in utero environment (36) . The attenuated PBM observed in both LBW groups in our study is of concern, because PBM is an important determinant of fracture risk later in life (9, 10) . Given the growing prevalence of osteoporotic fractures (37) , study of risk factors in fetal life is of major significance.
Strengths and limitations
The major strength of the study is the access to cohorts consisting of subjects with LBW followed from birth to adulthood, minimizing selection bias. Furthermore, we 
